 SAN FRANCISCO, Jan. 19, 2023 GLOBE NEWSWIRE AltruBio Inc. AltruBio or the Company, a clinical stage biotech company dedicated to the development of novel therapeutics for the treatment of immunological diseases with high unmet medical needs, today announced that David T. Rubin, M.D., Professor of Medicine at the University of Chicago and AltruBio Scientific ... The post AltruBio Announces Poster Presentation on Immune Checkpoint Enhancer, ALTB-168 at Crohns Colitis Congress 2023 app... 